Johanna G. van der Bom

Treatment-related risk factors of inhibitor development in previously untreated patients with hemophilia A: the CANAL cohort study

Samantha C. Gouw, Johanna G. van der Bom, H. Marijke van den Berg · Blood · 2007 · 487 citations

Medicine, Hematology, Pharmacotherapy +14

Factor VIII Products and Inhibitor Development in Severe Hemophilia A

Samantha C. Gouw, Johanna G. van der Bom, Rolf Ljung et al. · New England Journal of Medicine · 2013 · 436 citations · Full text

Medicine, Hematology, Pediatrics +16

Bleeding in carriers of hemophilia

Iris Plug, Eveline P. Mauser‐Bunschoten, Annette Bröcker‐Vriends et al. · Blood · 2006 · 369 citations · Full text

Medicine, Hematology, Hemostasis +7

Intensity of factor VIII treatment and inhibitor development in children with severe hemophilia A: the RODIN study

Samantha C. Gouw, H. Marijke van den Berg, Kathelijn Fischer et al. · Blood · 2013 · 323 citations

Medicine, Hematology, Pediatrics +17

Mortality and causes of death in patients with hemophilia, 1992–2001: a prospective cohort study

Iris Plug, Johanna G. van der Bom, Marjolein Peters et al. · Journal of Thrombosis and Haemostasis · 2006 · 280 citations · Full text

Medicine, Hematology, Clinical Epidemiology +10